Search Results
Viewing: 761-770 of 11824 | All
Article
About Us
The BCR at Nationwide Children's Hospital is composed of six primary workgroups: Client Services Logistics Histology Pathology and Virtual Microscopy Molecular Informatics This subdivision of workgroups creates a modular system which allows the BCR flexibility and variety in the functions it
Article
ALCHEMIST
The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, is a group of clinical trials for patients with certain types of early-stage non-small cell lung cancers (NSCLC) that have been treated surgically.
Article
Exceptional Responders
The National Cancer Institute (NCI) has embarked on the Exceptional Responders (ER) Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
Article
Burkitt Lymphoma Genome Sequencing Project
The BCR serves as the biospecimen processing core for the Burkitt Lymphoma Genome Sequencing Project (BLGSP). Burkitt lymphoma is a type of non-Hodgkin lymphoma that occurs most often in children and young adults.
Article
Clinical Trials Sequencing Project
The Clinical Trials Sequencing Project (CTSP) will promote the use of genomics to explain the molecular basis of response and resistance to therapies studied in National Cancer Institute (NCI)-sponsored clinical trials of the National Clinical Trials Network (NCTN).
Article
Cancer Driver Discovery Project
The Cancer Driver Discovery Project (CDDP) aims to identify driver mutations that occur in two percent or more of cancer cases. Further explanation of the molecular causes of cancer through deeper characterization of tumors is expected to yield insights into tumor biology, leading to better
Article
Contact Us
Biospecimen Core Resource The Abigail Wexner Research Institute at Nationwide Children's Hospital 700 Children's Drive Columbus, Ohio 43205 Main Phone: (614) 355-2919 Key Contacts at the BCR Jay Bowen Principal Investigator Sara Coppens Project Manager Hilary Petrello Client Services Kevin Bennett
Article
HIV+ Tumor Molecular Characterization Project
The HIV+ Tumor Molecular Characterization Project (HTMCP) will study 100 cases each of diffuse large B-cell lymphoma, lung cancer, and cervical cancer.
Media Center
See the latest news coming out of the Center for Injury Research and Policy including press releases, announcements about recent awards, publications, studies, and events, as well as upcoming media trainings.